Skip to main content
CURE logo
CURE
(NYSEARCA)
Direxion Daily Healthcare Bull 3X ETF
$116.10-- (--)
Loading... - Market loading

CURE ETF: Direxion Daily Healthcare Bull 3X ETF - Price, Holdings & Analysis

Direxion Daily Healthcare Bull 3X ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$112.67 - $116.81
52-Week High$126.70
52-Week Low$66.00
Open$112.87
Volume67.82K
Average Volume (3M)83.01K
Assets (AUM)163.75M
Expense Ratio0.94%
Total Holdings70
Inception DateJun 14, 2011
1 Day Change3.54%
1 Month Change14.08%
6 Month Change-0.10%
YTD Change2.76%
1 Year Change46.13%
52-Week Change44.56%
5 Year Change-1.98%
10 Year Change222.50%
50-Day MA$103.49
200-Day MA$102.95
RSI55.91
Stochastic %K44.53
Stochastic %D34.15
Annual Dividend$1.91
Dividend Yield1.64%
Last Dividend Ex-DateSep 30, 2026
Dividend Growth YoY73.70%
Years Dividend Growth1

Frequently Asked Questions About Direxion Daily Healthcare Bull 3X ETF

What is the current price of CURE?

The latest CURE price is $116.10. The 52-week range is $66.00–$126.70. CURE has returned 44.6% over the past 52 weeks.

What is the expense ratio for CURE?

CURE's annual expense ratio is 0.94%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.

Does CURE pay dividends?

Yes, CURE pays a 1.64% dividend yield. The last ex-dividend date was 2026-09-30. View full dividend history in the Dividends section.

What are the top holdings of CURE?

CURE's largest holdings are Eli Lilly and Company (11.7%), Johnson & Johnson (7.5%), AbbVie Inc. (5.2%) (combined weight: 24.4%). The fund holds 70 total positions. View the complete portfolio breakdown in the Holdings section.

How does CURE compare to similar ETFs?

Compare CURE (0.94% expense ratio, $164M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.